Sections 6001, 6002, and 6003 of the Deficit Reduction Act of 2005 (DRA) made significant changes to the Medicaid prescription drug provisions of the Social Security Act. These changes include revising the definition of average manufacturer price (AMP), establishing a new formula for calculating Federal upper limits (FULs), requiring rebates for certain physician-administered drugs, and clarifying rebate liability for authorized generic drugs. We have provided several resources and documents that will help stakeholders understand the impact of these provisions on the Medicaid program and keep informed about how CMS is implementing these provisions. These materials can be found on the Deficit Reduction Act web section by clicking on the link below.
Page Last Modified: 05/04/2009 9:20:24 AM
Help with File Formats and Plug-Ins
Submit Feedback
|